Fri, January 5, 2024
Thu, January 4, 2024
Wed, January 3, 2024
Tue, January 2, 2024
Fri, December 29, 2023
Thu, December 28, 2023
Wed, December 27, 2023
Tue, December 26, 2023
Fri, December 22, 2023

David Amsellem Upgraded (TEVA) to Hold and Increased Target to $12 on, Jan 3rd, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-increased-target-to-12-on-jan-3rd-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Amsellem of Piper Sandler, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Increased Target from $8 to $12 on, Jan 3rd, 2024.

David has made no other calls on TEVA in the last 4 months.



There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • Rajesh Kumar of "HSBC" Initiated at Strong Buy and Held Target at $13 on, Monday, December 18th, 2023
  • Ashwani Verma of "UBS" Upgraded from Hold to Strong Buy and Increased Target to $13 on, Monday, November 27th, 2023
  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $13 on, Friday, September 8th, 2023

Publication Contributing Sources